This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
PGC. Mol Psychiatry 2009; 14: 10–17.
Falconer DS . Introduction to Quantitative Genetics, 3rd edn. Longman Scientific and Technical, Essex, England, 1989.
Risch N, Merikangas K . Science 1996; 273: 1516–1517.
Zhao X, Leotta A, Kustanovich V, Lajonchere C, Geschwind DH, Law K et al. Proc Natl Acad Sci USA 2007; 104: 12831–12836.
Malaspina D, Harlap S, Fennig S, Heiman D, Nahon D, Feldman D et al. Arch Gen Psychiatry 2001; 58: 361–367.
Pickard BS, Millar JK, Porteous DJ, Muir WJ, Blackwood DH . Pharmacogenomics J 2005; 5: 81–88.
McClellan JM, Susser E, King MC . Br J Psychiatry 2007; 190: 194–199.
Geschwind DH . Cell 2008; 135: 391–395.
Keller MC, Miller G . Behav Brain Sci 2006; 29: 385–404; discussion 405–52.
Maher B . Nature 2008; 456: 18–21.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Mitchell, K., Porteous, D. GWAS for psychiatric disease: is the framework built on a solid foundation?. Mol Psychiatry 14, 740–741 (2009). https://doi.org/10.1038/mp.2009.17
Published:
Issue Date:
DOI: https://doi.org/10.1038/mp.2009.17
This article is cited by
-
The dynorphin/κ-opioid receptor system and its role in psychiatric disorders
Cellular and Molecular Life Sciences (2012)
-
Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree
Molecular Psychiatry (2011)
-
Response to Mitchell and Porteus
Molecular Psychiatry (2010)
-
Messages from hypothesis-driven genotyping: the case of schizoaffective disorder, bipolar type
Molecular Psychiatry (2010)